On Feb. 18, 2026, investors weighed ImmunityBio’s EU bladder cancer win against its long slide since IPO and fresh legal ...
News Medical on MSN
Polyploidy-induced senescence may influence aging and cancer risk
A new editorial was published in Volume 18 of Aging-US on February 8, 2026, titled "Polyploidy-induced senescence: Linking development, differentiation, repair, and (possibly) cancer?" In this ...
The FDA has accepted the new drug application (NDA) for tirabrutinib (ONO-4059), a highly selective, irreversible, second-generation Bruton tyrosine kinase (BTK) inhibitor developed for the treatment ...
Urological cancers, encompassing malignancies of the prostate, bladder, kidney, and testicles, present significant clinical challenges due to their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results